3-175096900-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_207015.3(NAALADL2):c.154A>G(p.Met52Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000198 in 1,613,348 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207015.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152074Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000362 AC: 9AN: 248668Hom.: 1 AF XY: 0.0000297 AC XY: 4AN XY: 134876
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1461274Hom.: 0 Cov.: 30 AF XY: 0.0000193 AC XY: 14AN XY: 726906
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152074Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.154A>G (p.M52V) alteration is located in exon 2 (coding exon 2) of the NAALADL2 gene. This alteration results from a A to G substitution at nucleotide position 154, causing the methionine (M) at amino acid position 52 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at